Status:

COMPLETED

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsors:

National Human Genome Research Institute (NHGRI)

Conditions:

Cardiovascular Disease

Eligibility:

All Genders

21-65 years

Phase:

NA

Brief Summary

Background: Hypertension is a risk factor for heart disease. Low-sodium diets rich in fruits, vegetables, and other healthy foods are a good way to reduce blood pressure in people with hypertension. ...

Detailed Description

The objective of this study is to implement a sodium intervention investigation to assess the effect of increased dietary sodium intake on changes in blood pressure, vascular function, microbiome, who...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • African American men and women who are former GENE-FORECAST participants between 21 and 65 years of age. This criterion is inclusive of self-identified AA of both Hispanic, Latino and non-Hispanic, Latino ethnicities. Normotensive participants with systolic blood pressure (SBP) \<140 mm Hg and diastolic blood pressure (DBP) \<90 mm Hg and the absence of a history of prior diagnosis of hypertension.
  • Willingness and ability to participate in study procedures.
  • EXCLUSION CRITERIA:
  • Individuals who are pregnant or breast-feeding.
  • Individuals with high blood pressure or a history of hypertension.
  • Individuals with a history of myocardial infarction, stroke, heart failure, diabetes, chronic liver or kidney diseases.
  • Individuals who are taking antihypertensive, antidepressants, antidiabetic and antibiotic medications.
  • Individuals currently participating in another NIH protocol.
  • Individuals unable to provide informed consent.

Exclusion

    Key Trial Info

    Start Date :

    January 22 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 8 2022

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT04717336

    Start Date

    January 22 2021

    End Date

    July 8 2022

    Last Update

    April 27 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892